Harmony Biosciences Holdings (HRMY)

Exchange
NASDAQ
Symbol
HRMY
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    34.13
  • High
    34.85
  • Low
    33.64
  • Close
    34.29
  • Volume
    812,457

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
62.98
Receivables turnover
7.40
Payables turnover
19.05
Working capital turnover
1.91
Days of inventory on hand (DOH)
5.80
Days of sales outstanding (DSO)
49.34
Number of days of payables
19.16
Fixed asset turnover
1,478.43
Total asset turnover
0.68
 Liquidity ratios
Current ratio
2.75
Quick ratio
2.61
Cash ratio
2.16
Cash conversion cycle
35.97
 Solvency ratios
Debt-to-assets ratio
0.22
Debt-to-capital ratio
0.28
Debt-to-equity ratio
0.38
Financial leverage ratio
1.74
Interest coverage
8.08
 Profitability ratios
Gross profit margin
84.01%
Operating profit margin
35.01%
Pretax margin
31.61%
Net profit margin
23.49%
Operating return on assets (Operating ROA)
23.67%
Return on assets (ROA)
15.88%
Return on total capital
29.75%
Return on equity (ROE)
27.59%